Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-12 Sale | 2026-01-12 7:07 pm | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 30,424 | $22.67 | $689,819 | 936,842 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 8:20 pm | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 54,343 | $25.1 | $1,363,841 | 259,934 (Direct) | View |
| 2025-12-22 Sale | 2025-12-22 5:52 pm | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 47,528 | $27.02 | $1,284,311 | 133,275 (Direct) | View |
| 2025-01-06 Sale | 2025-01-06 8:34 pm | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 57,291 | $14.92 | $855,017 | 261,805 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 6:23 pm | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 23,904 | $10.79 | $257,845 | 619,096 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-12 Option Award | 2026-01-12 7:07 pm | N/A 2036-01-11 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 582,000 | $0 | 936,842 (Direct) | View |
| 2026-01-12 Exercise | 2026-01-12 7:07 pm | N/A N/A | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 64,000 | $0 | 936,842 (Direct) | View |
| 2026-01-05 Exercise | 2026-01-05 8:20 pm | N/A N/A | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 114,334 | $0 | 259,934 (Direct) | View |
| 2025-12-22 Exercise | 2025-12-22 5:52 pm | 2025-12-22 2025-12-22 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 100,000 | $0 | 133,275 (Direct) | View |
| 2025-01-10 Option Award | 2025-01-10 5:58 pm | N/A 2035-01-09 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 480,000 | $0 | 480,000 (Direct) | View |
| 2025-01-06 Exercise | 2025-01-06 8:34 pm | N/A N/A | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 114,332 | $0 | 261,805 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-08 6:23 pm | N/A 2034-01-04 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 500,000 | $0 | 619,096 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:23 pm | N/A N/A | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 47,666 | $0 | 619,096 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 8:00 pm | N/A 2033-01-04 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 358,000 | $0 | 358,000 (Direct) | View |
| 2022-12-22 Option Award | 2022-12-23 7:30 pm | 2025-12-22 2025-12-22 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair & CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-01-15 Option Award | 2022-01-18 06:25 am | N/A 2032-01-14 | Zymeworks Inc. | ZYME | Galbraith Kenneth Chair, President & CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-05-13 Option Award | 2021-05-17 9:20 pm | N/A 2031-05-13 | MACROGENICS INC | MGNX | Galbraith Kenneth Director | 15,000 | $0 | 15,000 (Direct) | View |